Cargando…
Transarterial chemoembolization (TACE) plus sorafenib: a real winning combination?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791214/ https://www.ncbi.nlm.nih.gov/pubmed/33437815 http://dx.doi.org/10.21037/atm-20-4268 |
| _version_ | 1783633563007057920 |
|---|---|
| author | Adhoute, Xavier Anty, Rodolphe Bourlière, Marc |
| author_facet | Adhoute, Xavier Anty, Rodolphe Bourlière, Marc |
| author_sort | Adhoute, Xavier |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7791214 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77912142021-01-11 Transarterial chemoembolization (TACE) plus sorafenib: a real winning combination? Adhoute, Xavier Anty, Rodolphe Bourlière, Marc Ann Transl Med Editorial Commentary AME Publishing Company 2020-12 /pmc/articles/PMC7791214/ /pubmed/33437815 http://dx.doi.org/10.21037/atm-20-4268 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Adhoute, Xavier Anty, Rodolphe Bourlière, Marc Transarterial chemoembolization (TACE) plus sorafenib: a real winning combination? |
| title | Transarterial chemoembolization (TACE) plus sorafenib: a real winning combination? |
| title_full | Transarterial chemoembolization (TACE) plus sorafenib: a real winning combination? |
| title_fullStr | Transarterial chemoembolization (TACE) plus sorafenib: a real winning combination? |
| title_full_unstemmed | Transarterial chemoembolization (TACE) plus sorafenib: a real winning combination? |
| title_short | Transarterial chemoembolization (TACE) plus sorafenib: a real winning combination? |
| title_sort | transarterial chemoembolization (tace) plus sorafenib: a real winning combination? |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791214/ https://www.ncbi.nlm.nih.gov/pubmed/33437815 http://dx.doi.org/10.21037/atm-20-4268 |
| work_keys_str_mv | AT adhoutexavier transarterialchemoembolizationtaceplussorafenibarealwinningcombination AT antyrodolphe transarterialchemoembolizationtaceplussorafenibarealwinningcombination AT bourlieremarc transarterialchemoembolizationtaceplussorafenibarealwinningcombination |